HB287
(Title)
(New Title) removing fentanyl and xylazine testing equipment from the definition of drug paraphernalia in the controlled drug act.
Docket of HB287
Bill Versions
Introduced
As Amended by the Senate
Version adopted by both bodies
CHAPTERED FINAL VERSION
Amendments
2023-2060s
Committee Reports
Sen Comm Rpt
(5/31/23)
Sen Hearing Rpt
(5/5/23)
Body
Docket Description
H
Introduced (in recess of) 01/05/2023 and referred to Criminal Justice and Public Safety HJ 3 P. 9
H
Public Hearing: 01/18/2023 12:15 pm LOB 202-204
H
==CANCELLED== Executive Session: 02/03/2023 09:00 am LOB 202-204
H
Full Committee Work Session: 03/10/2023 09:00 am LOB202-204
H
Executive Session: 03/10/2023 10:00 am LOB 202-204
H
Committee Report: Ought to Pass 03/10/2023 (Vote 20-0; CC) HC 16 P. 5
H
Ought to Pass: MA VV 03/22/2023 HJ 10 P. 7
S
Introduced 03/23/2023 and Referred to Judiciary; SJ 12
S
Hearing: 05/02/2023, Room 100, SH, 01:45 pm; SC 20
S
Committee Report: Ought to Pass with Amendment # 2023-2060s, 06/01/2023; SC 24A
S
Committee Amendment # 2023-2060s, AA, VV; 06/01/2023; SJ 16
S
Ought to Pass with Amendment 2023-2060s, MA, VV; OT3rdg; 06/01/2023; SJ 16
H
House Concurs with Senate Amendment 2023-2060s (Rep. Roy): MA VV 06/15/2023 HJ 16 P. 2
S
Enrolled Adopted, VV, (In recess 06/29/2023); SJ 20
H
Enrolled (in recess of) 06/29/2023 HJ 17 P. 18
H
Signed by Governor Sununu 08/04/2023; Chapter 186; eff: 10/03/2023 HJ 17